Pàgina inicial > Resultats de la cerca: Boehncke, Wolf-Henning
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Dipòsit Digital de Documents de la UAB 3 registres trobats  La cerca s'ha fet en 0.00 segons. 
1.
24 p, 525.4 KB Elevating the Standard of Care for Patients with Psoriasis : 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative / Koren, Jan (EUROPSO, Polzela, Slovenia) ; Lambert, Jo (Ghent University) ; Thomsen, Simon F. (University of Copenhagen) ; McAteer, Helen (Psoriasis Association) ; Fabbrocini, Gabriella (University of Naples Federico II) ; Corazza, Valeria (Italian Psoriatic Association Friends of the Corazza Foundation) ; Jullien, Denis (Lyon-1 University) ; Augustin, Matthias (University Medical Center Hamburg-Eppendorf) ; Warren, Richard B. (University of Manchester) ; de Rie, Menno A. (University of Amsterdam) ; Lazaridou, Elizabeth (Aristotle University School of Medicine) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Guillevin, Loïc (Université Paris Descartes) ; Grosser, Marius (German Psoriasis Association) ; Boehncke, Wolf-Henning (University of Geneva) ; Universitat Autònoma de Barcelona
Despite advances in treatment options and the management of patients with psoriasis, considerable unmet needs remain. Our objective was to identify ways to elevate the standard of care for patients with psoriasis by combining the perspectives of three important stakeholders: patients, clinicians and payors, and define 'Calls to Action' designed to achieve the identified changes. [...]
2022 - 10.1007/s13555-022-00846-3
Dermatology and Therapy, december 2022, p. 1-24  
Registre complet - Creative Commons
2.
18 p, 504.6 KB Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis : Results from Greater Than 17,000 Patient-Years of Exposure / Armstrong, April W (Keck School of Medicine of the University of Southern California. Department of Clinical Research) ; Paul, Carle (Paul Sabatier University. Dermatology Department, Toulouse University Hospital (CHU)) ; Puig Sanz, Lluís (Institut d'Investigació Biomèdica Sant Pau) ; Boehncke, Wolf-Henning (University of Geneva. Department of Pathology and Immunology) ; Freeman, Michael (The Skin Centre, Benowa, QLD Australia) ; Torii, Hideshi (Tokyo Yamate Medical Center. Division of Dermatology) ; Papp, Kim (K Papp Clinical Research and Probity Medical Research) ; Griffiths, Christopher E. M. (NIHR Manchester Biomedical Research Centre. Dermatology Centre, Salford Royal Hospital, University of Manchester) ; Blauvelt, Andrew (Oregon Medical Research Center) ; Reich, Kristian (Skinflammation® Center, Hamburg, Germany) ; Gooderham, Melinda (Centre for Dermatology and Probity Medical Research, Peterborough, ON Canada) ; Terui, Tadashi (Nihon University School of Medicine. Department of Dermatology) ; Renda, Lisa (Eli Lilly and Company) ; Agada, Noah (Eli Lilly and Company) ; Xu, Wen (Eli Lilly and Company) ; Gallo, Gaia (Eli Lilly and Company) ; Lebwohl, Mark G. (Icahn School of Medicine at Mount Sinai. Department of Dermatology) ; Universitat Autònoma de Barcelona
Long-term safety data are critical for evaluating therapies for psoriasis. Ixekizumab has demonstrated efficacy and is well tolerated for the treatment of moderate-to-severe plaque psoriasis. We examined the safety and tolerability of up to 5 years of ixekizumab therapy in patients with psoriasis. [...]
2019 - 10.1007/s13555-019-00340-3
Dermatology and Therapy, Vol. 10 (november 2019) , p. 133-150  
Registre complet - Creative Commons
3.
11 p, 1.5 MB The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis / Girolomoni, Giampiero (University of Verona) ; Strohal, Robert (Federal Academic Teaching Hospital of Feldkirch) ; Puig Sanz, Lluís (Universitat Autònoma de Barcelona) ; Bachelez, Hervé (Institut Imagine (Paris, França)) ; Barker, Jonathan (King's College London) ; Boehncke, Wolf-Henning (University of Geneva) ; Prinz, Joerg (University of Munich)
Psoriasis is a chronic, immune-mediated disease affecting more than 100 million people worldwide and up to 2. 2% of the population. The aetiology of psoriasis is thought to originate from an interplay of genetic, environmental, infectious and lifestyle factors. [...]
2017 - 10.1111/jdv.14433
Journal of the European Academy of Dermatology and Venereology, Vol. 31, Issue 10 (October 2017) , p. 1616-1626  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem